CN EN

... Service Advantages

Core Advantages

Core Advantages

International Technology Cooperation

The first in China to introduce NK cell adoptive immunotherapy from Odaka Hospital (Japan) and realize clinical data sharing;

Jointly completed the iterative upgrade of NK-PLUS medium with the National Institutes of Health (NIH, US).

technical cooperation

Cooperation Network with Top-tier Hospitals (Grade A Tertiary Hospitals)

The first to cooperate with the Chinese PLA General Hospital in the application of NK cell therapy technology;
Collaborate with leading Chinese hospitals on cell research, integrating industry, academia, research to advance clinical applications.

Expert Team

CansBio assembles a dedicated team of doctors, masters, and senior researchers, collaborating closely with leading research institutions and hospitals worldwide. With deep expertise in cell storage, technology application, promotion, and drug development, the team is committed to advancing innovation in cell therapy technologies and products.

More

Xia Changqing

Chief Scientist; Professor, School of Medicine, University of Florida; Professor and Doctoral Supervisor, Capital Medical University.

More

Haruji Odaka

Chairman of Medical Progress Association, Japan Medical Corporation; President of Odaka Hospital, Tokyo, Japan; Member of the Japan Medical Association and the Japanese Society for Immunology.

More

Ling Xia

Postdoctoral Fellow, Kumamoto University (Japan); Expert in the field of regenerative medicine in Japan; Professor, Guilin Medical University.

More

Han Yan

Chief Physician and Professor, Department of Plastic and Reconstructive Surgery, the First Medical Center of the Chinese PLA General Hospital; Director of the Plastic and Aesthetic Center, Peking University International Hospital; Vice President of the Society of Aesthetic and Plastic Surgeons, Chinese Medical Doctor Association.

More

Wang Yuzhuo

Fellow of the Canadian Academy of Health Sciences; Professor, University of British Columbia (Canada); Distinguished Scientist, British Columbia Cancer Agency.

More

Wang Ningli

President of Henan Academy of Medical Sciences; Director of the Eye Center, Beijing Tongren Hospital; Director of Beijing Institute of Ophthalmology; President of the Academy of Sciences, Capital Medical University.

More

Feng Zhichun

President of Bayi Children's Hospital Affiliated to the PLA Army General Hospital; Director of the Military Pediatric Research Institute; Professor, Chief Physician, Doctoral Supervisor.

More

Ma Jianming

Chairman of the Ocular Oncology Professional Committee, Ophthalmologist Branch of the Chinese Medical Doctor Association; Chairman of the Ocular Oncology and Orbital Disease Subcommittee, Ophthalmologist Branch of Beijing Medical Association.

More

Wang Jigeng

Secretary-General of the Medical Aesthetics and Cosmetology Branch, Chinese Medical Association; Director-General of the Society of Aesthetic and Plastic Surgeons, Chinese Medical Doctor Association.

More

Tang Xiangfeng

Chief Physician, Department of Pediatrics, the Seventh Medical Center of the PLA General Hospital; Member of the Pediatric Rheumatology Group, Pediatric Branch of Beijing Medical Association; Member of the Rare Disease Rheumatology Group, Beijing Medical Association.

More

ISO9001

CNAS

GMP

AABB

International Standardized Production and Certification System​

High-standard integrated service

01Quality Management System: Certified under ISO 9001 Quality Management System and CNAS Laboratory Accreditation.

02Comprehensive Quality Management​:Implement comprehensive quality management in accordance with GMP and AABB standards.

03Benchmarking and Quality Trust: Products benchmarked against NIFDC (National Institutes for Food and Drug Control) standards, establishing the industry's highest benchmark for a quality trust system.

Cell Preparation Purity and Activity: Industry-leading purity and activity in cell preparation, with transparent and quantifiable technical indicators.

Integrated Storage and Blood Collection Service: Offer integrated storage and blood collection services, leveraging collection and testing capabilities from tertiary Grade A hospitals combined with a proprietary storage system.

Full-Process Standardized Management: Implement standardized management throughout the entire process.

system

Full-Chain Traceability System

Full-cycle product matrix

End-to-End Product Ecosystem

Build a three-in-one business ecosystem covering tumor immunotherapy, anti-aging, and chronic disease management;

Adopt a "technology R&D - clinical translation - industry incubation" model to promote the co-construction of industry standards.

The entire product line is underwritten by PICC for product liability insurance, providing dual guarantee for technical safety

Certificate of Honor

ISO9001证书（中文版）

ISO9001证书（英文版）

  • 康思葆生物获CNAS国家实验室认可

  • 康思葆生物获CNAS国家实验室认可

  • 试验室基地行政审批备案

  • 第二类医疗器械经营备案

  • 润妍泌语检测报告封面

  • 润妍泌语检测报告封面

  • 蛋白细胞偶联物其制备方法与用途

  • 一种高效扩增字体NK细胞的培养皿

  • 蛋白细胞偶联物其制备方法与用途

  • 蛋白细胞偶联物其制备方法与用途

  • 蛋白细胞偶联物其制备方法与用途

  • “一种预防或治疗与蛋白质-细胞结合物，恶性肿瘤，由病原微生物和自身免疫疾病引起的感染性疾病中的蛋白质相关的一种或多种疾病的方法”获美专利授权

  • “一种预防或治疗与蛋白质-细胞结合物，恶性肿瘤，由病原微生物和自身免疫疾病引起的感染性疾病中的蛋白质相关的一种或多种疾病的方法”获美专利授权

  • “蛋白细胞偶联物其制备方法与用途”获日本专利授权

  • 一种便于冷藏转运的生物安全罐

  • 一种保温箱及自动液氮罐

  • 一种便于更换电极头的美容仪

  • 一种药液熏蒸物化的手持美容仪

  • 免疫细胞医学研究试验室基地

  • GMP细胞制备中心

  • 检测中心（CNAS标准）

  • 研发中心

  • 国家高新技术企业

  • 中关村高新技术企业

  • 北京市”创新型”中小企业

  • 日本小田医院集团北京康思葆免疫研究中心

  • 北京市“专精特新”中小企业

  • 中国医药生物技术学会团体会员单位

  • 眼颅压力失稳疾病诊疗技术研究中心

  • 基因工程与细胞治疗联合研发平台

  • 自体免疫细胞储存服务机构品信星级认证

  • 中国人保产品责任险承保企业

  • Address
    Unit 2, Building 11, Courtyard 20, Kechuang 14th Street, Beijing Economic and Technological Development Zone

  • Tel
    010-52936373

  • Interested candidates can send their resumes to
    mzeng@cansbio.com or contact us by phone: 010-52936373

Copyright © 2025 康思葆（北京）生物技术有限公司. All Rights Reserved备案号：京ICP备2020041676号-1京公网安备 11030102011019号